Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years: an analysis by sex and age.
Birkenmaier I, Maul LV, Oyanguren I, Sorbe C, Fröhlich F, Schlapbach C, Heidemeyer K, Yawalkar N, Boehncke WH, Ring HC, Thyssen JP, Egeberg A, Micheroli R, Thomsen SF, Mainetti C, Cozzio A, Kündig TM, Levesque MP, Navarini A, Maul JT. Birkenmaier I, et al. Among authors: sorbe c. Arch Dermatol Res. 2024 Oct 1;316(9):654. doi: 10.1007/s00403-024-03375-5. Arch Dermatol Res. 2024. PMID: 39352439 Free PMC article.
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
Verardi F, Maul LV, Borsky K, Steinmann S, Rosset N, Pons HO, Sorbe C, Yawalkar N, Micheroli R, Egeberg A, Thyssen JP, Heidemeyer K, Boehncke WH, Conrad C, Cozzio A, Pinter A, Kündig T, Navarini AA, Maul JT. Verardi F, et al. Among authors: sorbe c. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):719-731. doi: 10.1111/jdv.19730. Epub 2023 Dec 12. J Eur Acad Dermatol Venereol. 2024. PMID: 38084852
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest.
Reich K, Mrowietz U, Sorbe C, von Kiedrowski R, Diemert S, Schaeffer L, Kirsten N, Ben-Anaya N, Augustin M. Reich K, et al. Among authors: sorbe c. J Dermatolog Treat. 2022 Dec;33(8):3170-3177. doi: 10.1080/09546634.2022.2115285. Epub 2022 Sep 1. J Dermatolog Treat. 2022. PMID: 35981144 Free article.
Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form.
Blome C, von Stülpnagel CC, Augustin M, Mrowietz U, Reich K, Muehlan H, Kirsten N, Langenbruch AK, Sorbe C, Klein TM. Blome C, et al. Among authors: sorbe c. Br J Dermatol. 2022 Oct;187(4):588-589. doi: 10.1111/bjd.21593. Epub 2022 May 31. Br J Dermatol. 2022. PMID: 35383904 No abstract available.
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study.
Maul JT, Augustin M, Sorbe C, Conrad C, Anzengruber F, Mrowietz U, Reich K, French LE, Radtke M, Häusermann P, Maul LV, Boehncke WH, Thaçi D, Navarini AA. Maul JT, et al. Among authors: sorbe c. Br J Dermatol. 2021 Dec;185(6):1160-1168. doi: 10.1111/bjd.20387. Epub 2021 Jun 22. Br J Dermatol. 2021. PMID: 33837519
22 results